Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
424308, 424317, 560 35, 560119, 562440, 562501, C07C13102, A61K 31215, A61K 31195
Compounds useful in treating cardiovascular disorders are the carboxylic acids depicted in formulas (1) and (2) ##STR1## as well as their pharmaceutically acceptable, non-toxic salts and esters, wherein:
patent: 3872169 (1975-03-01), Bellina
patent: 3950420 (1976-04-01), Sawaki et al.
patent: 4006179 (1977-02-01), Bernady et al.
patent: 4161538 (1979-07-01), Terada et al.
patent: 4211789 (1980-07-01), Roman et al.
patent: 4219563 (1980-08-01), Powell
patent: 4324579 (1982-04-01), Farge et al.
Bindra and Bindra, Prostaglandin Synthesis, Academy Press, NY, 1977, pp. 266-271.
Journal of Organic Chemistry, vol. 37, No. 14, 1972, pp. 2363-2364, Greico, P. A., "Cyclopentenones, An Efficient Synthesis of cis-Jasmone".
Krubiner Alan M.
Moran Tom M.
Scott Patricia M.
Syntex (U.S.A.) Inc.
(3.2.0) Bicycloheptanone oxime ethers with therapeutic propertie does not yet have a rating. At this time, there are no reviews or comments for this patent.If you have personal experience with (3.2.0) Bicycloheptanone oxime ethers with therapeutic propertie, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and (3.2.0) Bicycloheptanone oxime ethers with therapeutic propertie will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-947239